Login

Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School. 00:10:00

Share On Facebook Share On Twitter

Chang Ching Wu CEO. Chief Executive Officer

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
David joined Girard Advisory Services, LLC in 2005 and contributes to Girard Investment Currents, addressing key financial questions for 2024 under Univest.
00:10:00
Standard Chartered Bank's Evolution in a Dynamic Global Landscape | Bill Winters, CEO , Standard Chartered Bank.
00:10:00
Retirement Revealed: Insights from Barry LaValley | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies.
00:00:00
Dr Luís Henrique Wolff Gowdak , Mayo Clinic
00:10:00
Exploring the Depths: A Conversation with Mattias Johansson, CEO of Bravida | Mattias Johansson - CEO of Bravida Holding
00:10:00
At the 25 Years MCI event, Christoph Vilanek of freenet AG and Thierry Bernard, CEO of QIAGEN N.V., engage in a distinguished guest live talk.
00:10:00
Navigating Distressed Markets: Key Insights on Contrarian Strategies | Simon Mawhinney - Chief Investment Officer, Allan Gray Australia
00:10:00
Chris Cairns presents Stavely Minerals' high-grade copper-gold discovery in Western Victoria, Australia.
00:00:00
Michael Goldberg, President & CEO of Navidea Biopharmaceuticals, Inc.
00:10:00
Conservatism and Classical Music: Matthew Continetti's Insights|Alexander Boot,Professor,School of Transnational Governance
00:10:00
CEO Russell Bradford Highlights 1Bt Nickel-Cobalt Resource at Key Mining Event | Russell Bradford ,CEO , Aston Minerals Limited.

© 2017 - Neuhu+